Fecal Microbiota Transplant National Registry
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
Conditions:
🦠 Fecal Microbiota Transplantation 🦠 Clostridium Difficile Infection 🦠 Gut Microbiome
🗓️ Study Start (Actual) 20 September 2017
🗓️ Primary Completion (Estimated) August 2027
✅ Study Completion (Estimated) August 2027
👥 Enrollment (Estimated) 4000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Phoenix, Arizona, United States
📍 Los Angeles, California, United States
📍 Los Angeles, California, United States
📍 Redwood City, California, United States
📍 Roseville, California, United States
📍 San Francisco, California, United States
📍 Ventura, California, United States
📍 Hamden, Connecticut, United States
📍 Georgetown, District of Columbia, United States
📍 Hialeah, Florida, United States
📍 Miami, Florida, United States
📍 Naples, Florida, United States
📍 Chicago, Illinois, United States
📍 Chicago, Illinois, United States
📍 Evanston, Illinois, United States
📍 Maywood, Illinois, United States
📍 Urbana, Illinois, United States
📍 Indianapolis, Indiana, United States
📍 Kansas City, Kansas, United States
📍 New Orleans, Louisiana, United States
📍 Baltimore, Maryland, United States
📍 Bethesda, Maryland, United States
📍 Boston, Massachusetts, United States
📍 Boston, Massachusetts, United States
📍 Ann Arbor, Michigan, United States
📍 Ann Arbor, Michigan, United States
📍 Rochester, Minnesota, United States
📍 Rochester, Minnesota, United States
📍 Las Vegas, Nevada, United States
📍 Morristown, New Jersey, United States
📍 New Brunswick, New Jersey, United States
📍 Plainsboro, New Jersey, United States
📍 New York, New York, United States
📍 New York, New York, United States
📍 New York, New York, United States
📍 New York, New York, United States
📍 New York, New York, United States
📍 Rochester, New York, United States
📍 Chapel Hill, North Carolina, United States
📍 Portland, Oregon, United States
📍 Philadelphia, Pennsylvania, United States
📍 Providence, Rhode Island, United States
📍 Nashville, Tennessee, United States
📍 Houston, Texas, United States
📍 Temple, Texas, United States
📍 Morgantown, West Virginia, United States
📍 Madison, Wisconsin, United States
📍 Milwaukee, Wisconsin, United States
📍 Edmonton, Alberta, Canada

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Recipient Inclusion Criteria
    • * Ability to give informed consent
    • * Receiving FMT or other gut-related microbiota product within 90 days after providing consent
    • * Access to internet and/or telephone
    • * Donor Inclusion
    • * Ability to give informed consent
    • * Providing stool sample for FMT

    Exclusion Criteria:

    • * Incarceration
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 17 October 2017
  • First Submitted that Met QC Criteria 27 October 2017
  • First Posted 30 October 2017

Study Record Updates

  • Last Update Submitted that Met QC Criteria 29 January 2024
  • Last Update Posted 31 January 2024
  • Last Verified January 2024